Overview

Treatment of Acute Hepatitis C Virus Infection With Pegylated Interferon in Injection Drug Users

Status:
Completed

Trial end date:
2007-06-01

Target enrollment:

Participant gender:

Summary

Injection drug use accounts for transmission of a high proportion of Hepatitis C Virus (HCV) infections. The purpose of this trial is to investigate the effectiveness of pegylated interferon in treating injection drug users (IDUs) with acute HCV.

Phase:

Phase 4

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborator:

University of Washington

Treatments:

Interferons